Find an Expert
Search
Menu
Help
Report an issue
STEREOTACTIC ABLATIVE BODY RADIOTHERAPY (SABR) AS A CATALYST TO IMPROVE OUTCOMES FROM IMMUNOTHERAPY
| Funding period: 2020 - 2025
Active
Researchers
Shankar Siva